C103H148Br2N22O16S4 — CID 157245558
2-aminoethanol;2-bromopropanoic acid;(2S)-1-[(2S)-2-(2-bromopropanoylamino)-2-cyclohexylacetyl]-N-(4-phenyl-2,3-dihydrothiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-(2-hydroxyethylamino)propanoyl]amino]acetyl]-N-(4-phenyl-2,3-dihydrothiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(2-hydroxyethylamino)propanoyl]amino]acetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexylpropanoyl]-N-(4-phenyl-2,3-dihydrothiadiazol-5-yl)pyrrolidine-2-carboxamide (PubChem CID 157245558) has the molecular formula C103H148Br2N22O16S4 and a molecular weight of 2238.53 g/mol. Its IUPAC name is 2-aminoethanol;2-bromopropanoic acid;(2S)-1-[(2S)-2-(2-bromopropanoylamino)-2-cyclohexylacetyl]-N-(4-phenyl-2,3-dihydrothiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-(2-hydroxyethylamino)propanoyl]amino]acetyl]-N-(4-phenyl-2,3-dihydrothiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(2-hydroxyethylamino)propanoyl]amino]acetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexylpropanoyl]-N-(4-phenyl-2,3-dihydrothiadiazol-5-yl)pyrrolidine-2-carboxamide.
| Compound Name | 2-aminoethanol;2-bromopropanoic acid;(2S)-1-[(2S)-2-(2-bromopropanoylamino)-2-cyclohexylacetyl]-N-(4-phenyl-2,3-dihydrothiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-(2-hydroxyethylamino)propanoyl]amino]acetyl]-N-(4-phenyl-2,3-dihydrothiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(2-hydroxyethylamino)propanoyl]amino]acetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexylpropanoyl]-N-(4-phenyl-2,3-dihydrothiadiazol-5-yl)pyrrolidine-2-carboxamide |
|---|---|
| PubChem CID | 157245558 |
| Molecular Formula | C103H148Br2N22O16S4 |
| Molecular Weight | 2238.53 g/mol |
| Exact Mass | 2234.87 |
| IUPAC Name | 2-aminoethanol;2-bromopropanoic acid;(2S)-1-[(2S)-2-(2-bromopropanoylamino)-2-cyclohexylacetyl]-N-(4-phenyl-2,3-dihydrothiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-(2-hydroxyethylamino)propanoyl]amino]acetyl]-N-(4-phenyl-2,3-dihydrothiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(2-hydroxyethylamino)propanoyl]amino]acetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexylpropanoyl]-N-(4-phenyl-2,3-dihydrothiadiazol-5-yl)pyrrolidine-2-carboxamide |
| SMILES | CC(Br)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NC1=C(c2ccccc2)NNS1)C1CCCCC1.CC(Br)C(=O)O.C[C@@H](NCCO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NC1=C(c2ccccc2)NNS1)C1CCCCC1.C[C@H](C(=O)N1CCC[C@H]1C(=O)NC1=C(c2ccccc2)NNS1)C1CCCCC1.C[C@H](NCCO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1)C1CCCCC1.NCCO |
| InChI | InChI=1S/C26H38N6O4S.C26H36N6O4S.C24H32BrN5O3S.C22H30N4O2S.C3H5BrO2.C2H7NO/c2*1-17(27-14-16-33)23(34)28-22(19-11-6-3-7-12-19)26(36)32-15-8-13-20(32)24(35)29-25-21(30-31-37-25)18-9-4-2-5-10-18;1-15(25)21(31)26-20(17-11-6-3-7-12-17)24(33)30-14-8-13-18(30)22(32)27-23-19(28-29-34-23)16-9-4-2-5-10-16;1-15(16-9-4-2-5-10-16)22(28)26-14-8-13-18(26)20(27)23-21-19(24-25-29-21)17-11-6-3-7-12-17;1-2(4)3(5)6;3-1-2-4/h2,4-5,9-10,17,19-20,22,27,30-31,33H,3,6-8,11-16H2,1H3,(H,28,34)(H,29,35);2,4-5,9-10,17,19-20,22,27,33H,3,6-8,11-16H2,1H3,(H,28,34)(H,29,35);2,4-5,9-10,15,17-18,20,28-29H,3,6-8,11-14H2,1H3,(H,26,31)(H,27,32);3,6-7,11-12,15-16,18,24-25H,2,4-5,8-10,13-14H2,1H3,(H,23,27);2H,1H3,(H,5,6);4H,1-3H2/t17-,20+,22+;17-,20-,22-;15?,18-,20-;15-,18-;;/m1000../s1 |
| InChIKey | AVSHSLYFKDYPCR-BQCPQNBWSA-N |
| XLogP | 9.59 |
| TPSA | 530.97 Ų |
| H-Bond Donors | 20 |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 147 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2238.53 |
| LogP ≤ 5 | 9.59 |
| H-Bond Donors ≤ 5 | 20 |
| H-Bond Acceptors ≤ 10 | 30 |
| Structural Alerts | {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'sulphur_nitrogen_single_bond', 'substructure': 'N/A'} |
|---|